February 20, 2025
It is an honour for us to announce that Leyden Labs is among the select set of groundbreaking companies awarded funding under EU EIC Accelerator program. Only 71 out of 1211 applications were selected for funding, representing less than 6% of the submitted proposals. Reviewers recognized the importance and potential of our approach to develop non-vaccine solutions to fight back against the threat of respiratory viruses. We are grateful for both their endorsement and their investment in our mission.
Read more from the EIC here: EIC Accelerator – 71 companies selected in the most competitive funding round so far - European Commission
OUR NEW APPROACH | OUR TEAM | JOIN OUR MISSION | NEWS | CAREERS
Leyden Laboratories B.V.
Leiden Laboratory
Emmy Noetherweg 2
2333 BK Leiden
The Netherlands
Leyden Labs Asia Pte. Ltd.
79 Science Park Drive
#04-05, Cintech IV
Singapore 118264
© Leyden Labs, 2023 | Privacy Statement | Design by Ape to Zebra